文献速递神经介入DSA

血流导向装置内放置支架可提高动脉瘤闭塞率

Placement of a Stent within a Flow Diverter Improves Aneurysm Occlusion Rates.
PubMed 文献 · AJNR Am J Neuroradiol · 2019-10-03

回顾性比较单纯Surpass血流导向装置与在其内加放支架两组患者的临床和造影随访结果;支架组动脉瘤更大(14.8 vs 9.1 mm,P < .001),9-12个月完全闭塞率更高(93.9% vs 73.2%,P = .019),临床显著不良事件和早期闭塞率无显著差异。

要点

  • 血流导向装置内加放支架后9-12个月完全闭塞率93.9% vs 单纯装置组73.2%(P = .019)。
  • 支架组动脉瘤直径大于单纯装置组(14.8 vs 9.1 mm,P < .001)。
  • 两组临床显著不良事件率及0-3、3-6个月完全闭塞率无统计学差异。

核心结论

  • 血流导向装置内放置支架可提高动脉瘤完全闭塞率,作者认为该结果源于颅内支架更高径向支撑力改善了血流导向装置的贴壁。

研究设计与样本

  • 回顾性评估所有接受Surpass血流导向装置治疗的患者,排除既往已置入支架及使用脚手架支架、第二枚血流导向装置或瘤内装置的操作;单纯Surpass组35例(41个动脉瘤),支架组33例(35个动脉瘤),比较患者和动脉瘤特征及临床和影像随访结果,并与支架辅助弹簧圈栓塞比较。

关键影像表现/征象

  • 支架组动脉瘤较单纯装置组更大(14.8 vs 9.1 mm,P < .001)。
  • 两组年龄、体重、性别、血栓栓塞事件史、吸烟、血小板抑制水平、高血压、高脂血症、糖尿病、恶性肿瘤及动脉瘤位置无统计学差异。

诊断标准与关键数值

  • 0-3个月完全闭塞率:支架组73.3% vs 单纯装置组61.3%(P = .31),无统计学差异。
  • 3-6个月完全闭塞率:支架组84.8% vs 单纯装置组70.2%(P = .14),无统计学差异。
  • 9-12个月完全闭塞率:支架组93.9% vs 单纯装置组73.2%(P = .019),支架组更高。
  • 最终随访完全闭塞率:支架组93.9% vs 单纯装置组82.9%(P = .14),仅见升高趋势。

临床应用与阅片要点

  • 支架组0-3、3-6个月完全闭塞率与单纯装置组无显著差异,9-12个月支架组完全闭塞率更高(93.9% vs 73.2%,P = .019)。
  • 作者认为支架组闭塞率提高可能源于颅内支架更高径向支撑力改善血流导向装置贴壁。

局限性

  • 原文为回顾性评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Placement of a stent within a flow diverter has been described previously but its consequences have not been analyzed. We evaluated the clinical and angiographic results of stent placement within a flow diverter during the same treatment session.

MATERIALS AND METHODS: All patients treated with a Surpass flow diverter were retrospectively evaluated. Patients with previously deployed stents and procedures in which scaffolding stents, a second flow diverter, or intrasaccular devices were used were excluded. Patient and aneurysm characteristics and clinical and imaging follow-up results were compared between stented and nonstented Surpass flow-diverter groups and stent assisted coiling.

RESULTS: Thirty-five patients (41 aneurysms) were treated with a Surpass flow diverter only (monotherapy group), and in 33 patients (35 aneurysms), a stent was placed within the Surpass flow diverter (stented group). Stents were placed inside the Surpass flow diverter for a variety of reasons at the operator's discretion. No statistical difference was noted between the 2 groups in age, body weight, sex, history of thromboembolic events, smoking, platelet inhibition levels, hypertension, hyperlipidemia, diabetes mellitus, malignancy, and aneurysm location. Aneurysms in the stented group were larger than those in the monotherapy group (14.8 versus 9.1 mm, P < .001). The rate of clinically significant adverse events and complete aneurysm occlusion rates at 0-3 and 3-6 months (73.3% versus 61.3%, P = .31, and 84.8% versus 70.2%, P = .14) were similar. At 9-12 months, a significantly higher proportion of aneurysms in the stented group achieved complete occlusion (93.9% versus 73.2%, P = .019). There was a trend toward a higher obliteration rate on final follow-up in the stented group (93.9% versus 82.9%, P = .14).

CONCLUSIONS: Placement of a stent within a flow diverter increases the rate of aneurysm occlusion. We propose that these results are from improved flow-diverter apposition due to the higher radial force of intracranial stents.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Ocal O, Peker A, Balci S, et al. Placement of a Stent within a Flow Diverter Improves Aneurysm Occlusion Rates. AJNR Am J Neuroradiol. 2019. PMID: 31582390. doi:10.3174/ajnr.A6237

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。